Orange Book product · Generic (ANDA)
NARATRIPTAN
NARATRIPTAN HYDROCHLORIDE
At a glance
Feb 28, 2011
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 28, 2011
15 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
NARATRIPTAN HYDROCHLORIDE
Strength
EQ 1MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 200502
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of NARATRIPTAN HYDROCHLORIDE
- 1998AMERGEBrand (NDA)
NDA 020763 · GLAXOSMITHKLINE LLC
- 2012NARATRIPTANGeneric (ANDA)
ANDA 202431 · AUROBINDO PHARMA USA
- 2012NARATRIPTANGeneric (ANDA)
ANDA 091441 · ORBION PHARMS
- 2011NARATRIPTANGeneric (ANDA)
ANDA 091373 · APOTEX CORP
- 2011NARATRIPTANGeneric (ANDA)
ANDA 091552 · SUN PHARM INDS LTD
- 2010NARATRIPTANGeneric (ANDA)
ANDA 091326 · PADAGIS US
- 2010NARATRIPTANGeneric (ANDA)
ANDA 078751 · ANI PHARMS
- 2010NARATRIPTANGeneric (ANDA)
ANDA 090288 · CHARTWELL RX
- 2010NARATRIPTANGeneric (ANDA)
ANDA 090381 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
